MHRA Guidance on National Assessment Procedure for Marketing Authorisation Applications The MHRA has published a guidance on the national assessment procedure for marketing authorisation (MA) applications. MHRA Guidance on National Assessment Procedure for Marketing Authorisation Applications
MHRA Publishes Updated Statutory Fees for Medicines (2025–2027) The MHRA has published updated statutory fees for medicines, following a public consultation and response process. MHRA Publishes Updated Statutory Fees for Medicines (2025–2027)
CMDh Report – March 2025 Meeting The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published the report from the meeting held on 25-26 March 2025. CMDh Report – March 2025 Meeting
MHRA Marketing Authorisations Granted 15 to 31 March MHRA granted 1 OTC licence during 15-31 March 2025. MHRA Marketing Authorisations Granted 15 to 31 March
Regulatory Fees for British Chemicals Sector Reduced New legislation to cut UK REACH costs for chemical businesses has come into force as part of the Government’s Plan for Change. Regulatory Fees for British Chemicals Sector Reduced
Commission Report on the Work of HERA The EC has published a report assessing the work of the Commission's Health Emergency Preparedness and Response Authority (HERA) since its creation over three years ago. Commission Report on the Work of HERA
MHRA Releases February 2025 Performance Data The Medicines and Healthcare products Regulatory Agency (MHRA) has published its performance data for February 2025. MHRA Releases February 2025 Performance Data
DHSC Public Appointments: October 2024 – March 2025 The Department of Health and Social Care (DHSC) has announced its non-executive appointments for the period from October 2024 to March 2025. DHSC Public Appointments: October 2024 – March 2025
MHRA Safety Roundup Launch MHRA has launched a new safety bulletin, the MHRA Safety Roundup. This will be published in the last week of each month and includes a summary of all safety alerts (including Drug Safety Updates) published during the month. MHRA Safety Roundup Launch
Innovate UK – New Executive Chair Selected Tom Adeyoola has been selected as the preferred head of Innovate UK. Once confirmed by parliament, he will act as Chair and will be part of the largest national public research funder, helping businesses turn cutting-edge ideas into real-world products. Innovate UK – New Executive Chair Selected
European Medicines Agencies Network Strategy (EMANS) 2028 Published The European Medicines Agency (EMA) has published the European Medicines Agencies Network Strategy (EMANS) 2028: Seizing opportunities in a changing medicines landscape. European Medicines Agencies Network Strategy (EMANS) 2028 Published
MHRA Marketing Authorisations Granted 1 to 14 March MHRA granted 2 OTC licences during 1-14 March 2025. MHRA Marketing Authorisations Granted 1 to 14 March
